Diabetic ketoacidosis inducing myocardial infarction secondary to treatment with dapagliflozin: a case report

Sodium‐glucose cotransporter 2 (SGLT2) inhibitors are able to provoke diabetic ketoacidosis (DKA) with absence or low levels of ketone bodies in urine and slightly elevated blood glucose levels, which could delay the diagnosis; however, the presence of high urine output, due to the excretion of gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil‐Perdomo, José M., Fariña González, Tomás F., Jordán‐Arias, Benjamín, Domingo‐Marín, Sara, González Armengol, Juan J., Martínez‐Sagasti, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458028/
https://www.ncbi.nlm.nih.gov/pubmed/28588816
http://dx.doi.org/10.1002/ccr3.858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458028/
https://www.ncbi.nlm.nih.gov/pubmed/28588816
http://dx.doi.org/10.1002/ccr3.858

Ejemplares similares